Credentialing the AI Doctor: The FDA's Blueprint for Generative AI

Podcast: AI in Medicine - curated summaries making complex issues easy to understand · Mike Rawson

Opublikowano: 2026-10-13

The FDA is asking the healthcare industry how to regulate generative AI medical devices. We unpack their proposed competency-based approach, which evaluates AI less like software and more like a human medical resident. Key points Generative AI requires new regulatory frameworks because it produces variable outputs to similar inputs and can evolve after deployment.The FDA proposes a two-axis framework to assess risk based on device activity (how independently it acts) and the consequences of an incorrect output.A new competency-based premarket evaluation would mirror human clinician credentialing, using robust benchmarking and clinical confirmation.Postmarket monitoring...